CA9 and neoplasm: Based on this concept, we developed a saccharin‐based PET radiopharmaceutical for the diagnosis of CA IX‐overexpressed tumor cells and quantitatively evaluated the properties of 68Ga‐NOTA‐SAC by an in vitro and in vivo study.